ReviewCurrent opinion in urology2014
Nephron-sparing surgery for multifocal and hereditary renal tumors.
Review in Current opinion in urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.World journal of urology · 2026Guideline
- Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes.Current oncology (Toronto, Ont.) · 2026Article
- Is Open Partial Nephrectomy Still an Option in the Robotic Era?Current urology reports · 2026Review
- Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kinetics.Urologic oncology · 2025Article
- Clinical, Pathologic, and Genetic Correlates of Nuclear Grade in von Hippel-Lindau-associated Renal Cell Carcinoma.Urology · 2025Article
- Feasibility and perioperative outcomes of re-operative retroperitoneal robotic partial nephrectomy.Urologic oncology · 2025Article
- Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases.Urologic oncology · 2025Article
- Understanding the Metabolic Effects of Surgically Induced Renal Ischemia in Humans: A Temporal Approach.Metabolites · 2025Article
- Repeat robotic nephron-sparing surgery for metachronous multifocal tumors in a solitary kidney: a case report.Journal of medicine and life · 2025Article
- A Decade of Surgical Management of Renal Cell Carcinoma with IVC Thrombus and Bilateral Renal Tumors: Emphasis on Auto-transplantation.Journal of kidney cancer and VHL · 2025Article
- Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses.The Journal of urology · 2024Article
- Article
- A novel multiplex score to predict outcomes of partial nephrectomy for multiple tumors.Urologic oncology · 2023Article
- A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.American journal of medical genetics. Part A · 2023Article
- Review
- Review
- Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes.Endocrine · 2021Review
- Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
- Re: Multiple Tumor Excisions in Ipsilateral Kidney Increase Complications After Partial Nephrectomy (From: Maurice MJ, Ramirez D, Nelson R, et al. J Endourology 2016;30:1200-1206).Journal of endourology · 2017Article
- Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau.Urology case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
purpose of reviewDespite the controversy surrounding the benefits of nephron-sparing surgery, multiple absolute indications for nephron-sparing surgery still exist, including the classic indications of hereditary and bilateral kidney tumors. RECENT
findingsMultiple genetic mutations have been identified which lead to hereditary kidney cancer conditions. These are briefly reviewed because the surgical management of hereditary kidney tumors depends on the genetic and histologic subtypes involved. Clear understanding of these hereditary conditions is crucial for proper surgical management of these tumors. SUMMARY: Complex partial nephrectomy for multiple renal tumors, or multiplex partial nephrectomy, requires not only exceptional surgical skills but expertise of numerous nonsurgical methodologies, such as hands-on intraoperative ultrasonography and interpretation of multiple imaging modalities. In addition, multidisciplinary management is crucial for optimal outcomes in patient care. This review evaluates the most advanced surgical techniques and perioperative management required to successfully care for these challenging cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.